Carbogen Amcis AG enters into co-investment agreement
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Savoir-faire, soutien politique : quelles sont les raisons de l attractivité française ?
europe1.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europe1.fr Daily Mail and Mail on Sunday newspapers.
India s Ab-drug-conjugate API manufacturer expands to Switzerland with CHF 15 M investment
India s Ab-drug-conjugate API manufacturer expands to Switzerland with CHF 15 M investment 29 April 2021 | News Dishman Carbogen Amcis announces that its subsidiary, Carbogen Amcis AG has entered into a co-investment agreement to create a state-of-the art facility to produce commercial antibody-drug-conjugate API
Photo Credit: Dishman Carbogen Amcis
The company’s subsidiary, Carbogen Amcis AG, pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced a joint funding agreement with a longstanding Japan-based customer to build a site extension at the Bubendorf site in Switzerland.
The expansion will be created adjacent to an existing manufacturing facility on the Bubendorf Switzerland Site. This important expansion will incorporate a new production line comprising of two 850 L reactors and one agitated filt